Andere Sprachen Pharmesis International Ltd.

Aktien

A14Y52

SG1BH6000003

BFK

Markt geschlossen - Singapore S.E. Andere Börsenplätze 02:58:51 29.04.2024			% 5 Tage	% 1. Jan.
0,111 ^SGD	-7,50 %		-7,50 %	+13,27 %

15.04.	Pharmesis' zurechenbarer Verlust für 2023 weitet sich aus	MT
15.04.	Pharmesis International Ltd. gibt das Ausscheiden von Frau Lin Yimin als Direktorin bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Pharmesis International Ltd. Announces Retirement of Lin Yimin as Non-Independent Non-Executive Director and Member of Audit Committee	13:20
Pharmesis’ Attributable Loss for 2023 Widens	15.04.
Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director	15.04.
Pharmesis Launches New Product Line	26.03.
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months and Full Year Ended 31 December 2023	28.02.
Pharmesis International Ltd. Announces Changes to the Composition of the Board and Board Committees	29.09.23
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	14.08.23
Pharmesis International Flags Losses for H1	09.08.23
Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2023	08.08.23
Pharmesis International Ltd. Announces Management Resignations	31.07.23
Pharmesis International Ltd. Appoints Lin Yimin as Non-Independent Non-Executive Director and A Member of Audit Committee	31.07.23
Pharmesis International Ltd. Announces Temporary Work Stoppages at its Manufacturing Facilities Located in Gulin County, Luzhou City, Sichuan Province	27.07.23
Pharmesis International Issues 4.6 Million Shares to Two Subscribers	06.04.23
Pharmesis International Gets Regulatory Nod to List 4.6 Million Shares	29.03.23
Pharmesis International to Issue 4.6 Million Shares to Two Subscribers	21.03.23
Pharmesis International Expects Loss in H2, FY22	28.02.23
Pharmesis International Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28.02.23
Pharmesis International's Attributable Loss Widens in H1	15.08.22
Pharmesis International Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	12.08.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Pharmesis International Ltd.

Aktien

A14Y52

SG1BH6000003

BFK

Andere Sprachen

Filter